BNTC: Prakiraan volume dodolan Benitec

Logo perusahaan publik Benitec Biopharma Inc (BNTC)

Benitec Biopharma Inc. is building a foundation for long-term earnings by utilizing proprietary DNA suppression methods for liver treatment. The company's target sales dynamics confirm these expectations, with the metric level standing at 0.00. Development relies on strict bioethics and ESG standards within laboratories, as well as a rigorous regulatory framework for the disposal of hazardous biomedical waste.

Volume dodolan sing dikarepake perusahaan: Benitec Biopharma Inc. (BNTC) kanggo 04.07.2022 - 15.11.2026

Rincian metrik keuangan lan pasar Benitec (BNTC)

Analisis komprehensif perusahaan:BNTC Benitec Biopharma
Produk merek Benitec Biopharma Inc

In the gene therapy sector, the success of Benitec Biopharma Inc. (BNTC) depends on the commercialization of the BB-301 platform amid intense patent disputes. This metric models potential sales between reports, assessing business scaling through a mathematical approximation of revenue. Analyzing the company's target sales level allows investors to filter out market noise and avoid purchasing the asset at the peak of unjustified optimism.

Pesaing langsung

Volume dodolan mangsa ngarep perusahaan TEM (Tempus AI)|Dodolan mangsa ngarep perusahaan Qiagen Group|Prakiraan pendapatan perusahaan Ionis Pharma IONS|RGEN - Volume dodolan mangsa ngarep perusahaan|RNA - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan CRSP (CRISPR Therapeutics AG)|Sema4 (WGS) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan RARE (Ultragenyx)|Volume dodolan mangsa ngarep perusahaan BEAM|Prakiraan volume dodolan Sarepta Corp|Prakiraan pendapatan perusahaan Twist Bioscience, Inc. (TWST)|Volume dodolan mangsa ngarep perusahaan 10x Genomics TXG|Prakiraan pendapatan perusahaan Intellia Therapeutics NTLA|Prakiraan volume pendapatan perusahaan STOK (Stoke Therapeutics, Inc.)|BLFS - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Wave Pharma|mazetx.com (MAZE) - Prakiraan pendapatan perusahaan|SION - Dodolan mangsa ngarep perusahaan|PRME (Prime Medicine Inc) - Prakiraan volume dodolan|Taysha Gene Therapies, Inc. - Pendapatan sing dikarepake perusahaan|Prakiraan volume dodolan QURE|MGTX: Pendapatan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan REGENXBIO RGNX|SLDB: Prakiraan pendapatan perusahaan|OCGN: Volume dodolan mangsa ngarep perusahaan|PACB - Prakiraan volume dodolan|DSGN: Prakiraan volume dodolan|RCKT - Dodolan mangsa ngarep perusahaan|FDMT: Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan LXEO (lexeotx.com)|Prakiraan pendapatan perusahaan Korro Bio Inc. (KRRO)|Prakiraan volume pendapatan perusahaan EDIT|Prakiraan volume dodolan SLN (Silence Therapeutics PLC)|Pendapatan mangsa ngarep perusahaan PRQR|CDXS - Prakiraan pendapatan perusahaan|SGMO (Sangamo Therapeutics) - Prakiraan pendapatan perusahaan|NAUT: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan MGX|DTIL (precisionbiosciences.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GBIO (Generation Bio Co.)|Prakiraan pendapatan perusahaan Boundless Bio (BOLD)|Exicure - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan IMNN (imunon.com)|Dodolan mangsa ngarep perusahaan Phio Pharmaceuticals (PHIO)|MBIO: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan RNAZ (transcodetherapeutics.com)|Bionano Genomics, Inc. (BNGO) - Prakiraan pendapatan perusahaan|APDN - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan BLUE|Prakiraan volume dodolan immunoprecise.com|Prakiraan volume dodolan OMGA|Dodolan mangsa ngarep perusahaan Singular Genomics Corp|Regulus Therapeutics - Volume dodolan mangsa ngarep perusahaan|SYRS (Syros Pharmaceuticals) - Pendapatan sing dikarepake perusahaan|Telesis Bio Inc. - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan TCON (TRACON Pharmaceuticals Inc.)|UBX: Prakiraan volume dodolan